Skip to main content
. 2011 Sep 26;17(Suppl 6):E1–E59. doi: 10.1111/j.1469-0691.2011.03672.x
Reference Objective Design Evidence
Drobnic et al. [488] To study aerosolised tobramycin vs. placebo in non‐CF bronchiectasis RCT 2B−
Barker et al. [489] To study aerosolised tobramycin vs. placebo in non‐CF bronchiectasis RCT 2B+